Brief: ScandiDos to start sales of Delta4 Phantom+ in US following FDA approval
Aug 20 (Reuters) - ScandiDos AB SDOS.ST :
* Says US FDA (Food And Drug Association) has approved Delta4 Phantom+ and therefore can
marketing and sales begin in USA
Source text: http://bit.ly/1Jk0kwI
Further company coverage: SDOS.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))